ABSTRACT Anti-Salmonella spp. egg yolk antibodies (IgY) simultaneously directed against Salmonella Enteritidis and Salmonella Typhimurium were tested to determine if their inclusion in feed decreased Salmonella spp. cecal colonization in experimentally infected broiler chickens. Egg yolk powder (EYP) was obtained by freeze-drying egg yolks containing anti-Salmonella spp. Immunoglobin Y was included in feed at 5 levels of concentration (0 to 5%). Feeds were formulated to similar nutrient levels and provided for ad libitum intake from d 1 to 28. Three days after initiation of feed treatments (d 4), chickens were co-challenged with equal numbers of Salmonella Enteritidis and Salmonella Typhimurium (2 × 10 6 cfu/bird). Cecal samples were recovered weekly over the experimental period (d 7 to 28) to enumerate Salmonella spp. The effect of antiSalmonella spp. IgY feed supplementation on growth performance of infected chickens was also evaluated during the same period. In comparison with the positive control treatment (PC), treatments involving EYP (T1, T2, T3, T4, and T5), whether containing antiSalmonella spp. IgY or not, significantly improved (P < 0.05) the growth performance of challenged chickens, but without reaching the performance levels of nonchallenged chickens (NC1 and NC2). However, no link can be established between the enhancement in growth performance of challenged birds and their contamination levels by Salmonella because in-feed incorporation of EYP had no significant effect on cecal colonization by Salmonella. Furthermore, the comparison of the 5 anti-Salmonella spp. IgY concentration levels in feed did not reveal any anti-Salmonella spp. IgY concentration effect on growth performance and Salmonella cecal colonization. These results suggest that anti-Salmonella spp. IgY would undergo denaturation and degradation after their passage through the animal gastrointestinal tract and reveal that components of EYP other than specific antibodies have a beneficial effect on growth performance.
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INTRODUCTION
Salmonella enterica serovars Enteritidis and Typhimurium are the primary cause of foodborne poisoning in Belgium (Collard et al., 2008) . Human contamination is related to the consumption of poultry products. Among these products, broiler chicken is the most important reservoir that can induce Salmonella to the human food chain (Gast, 1997) . Salmonella Enteritidis and Salmonella Typhimurium are of particular importance because they can colonize the chicken host without causing discernible illness in the infected chickens (Barrow et al., 1987; Ziprin et al., 1989 ) but lead to acute bacterial enteritis called salmonellosis in humans.
Broiler chickens may become contaminated with Salmonella before, during, or after the grow-out phase of production. They can acquire the bacterium as a result of transovarian transmission from infected parent flocks and also as a result of the cross-contamination between the bird and its contaminated environment (feces, contaminated feed, and drinking water). Several researchers reported that Salmonella spp. colonized the gastrointestinal tract of chickens persistently after oral inoculation. The primary site of colonization, in terms of the greatest numbers recovered, is the ceca (Michetti et al., 1992; Turner et al., 1998) . Salmonella intestinal colonization plays a significant role in carcass contami-nation during slaughter and processing (Heyndrickx et al., 2007) . Indeed, intestine removal has been associated with increasing bacterial counts on processed carcasses (Geornaras and von Holy, 2000; Heyndrickx et al., 2007) . Therefore, it is important to target Salmonella reduction strategies during the grow-out period. The cross-contamination risk between carcass and the finished product should be reduced during processing, if Salmonella carriage could be reduced in the gastrointestinal tract of the bird.
Passive immunization via the administration of pathogen-specific egg yolk antibodies (IgY) has recently been successfully applied in poultry to prevent or eliminate a variety of gastrointestinal infections such as those caused by Campylobacter jejuni (Tsubokura et al., 1997) and Salmonella Enteritidis (Gürtler et al., 2004; Kassaify and Mine, 2004; Rahimi et al., 2007) . However, to our knowledge, the use of specific IgY simultaneously directed against several enteric pathogens has not been previously explored in vivo, particularly in the case of Salmonella spp.
In previous work, we demonstrated that anti-Salmonella spp. IgY was effective in inhibiting Salmonella adhesion and growth in vitro (Chalghoumi et al., 2009) . Hence, the aim of the current study was to evaluate in vivo the efficiency of the oral administration of specific IgY simultaneously directed against Salmonella Enteritidis and Salmonella Typhimurium, as hyperimmunized egg yolk powder (HEYP), as prophylaxis in infected broiler chickens in a mixed challenge experiment.
MATERIALS AND METHODS
Egg Yolk Powder Preparation
Fifty 16-wk-old ISA Brown hens (Gallus domesticus, Volailles Lamballaises, Lamballe, France) certified unvaccinated against Salmonella and specific Salmonella spp.-free status were used for this experiment. The Salmonella-free status was checked and confirmed throughout the experiment. Hens were immunized with a Salmonella spp.-outer membrane proteins (OMP) mixture (1:1) obtained from Salmonella Enteritidis and Salmonella Typhimurium as described previously (Chalghoumi et al., 2008) . The Salmonella spp.-OMP mixture was suspended in sterilized PBS 0.15 M (400 µg/mL) and emulsified with an equal volume of Freund's complete adjuvant for the first immunization and Freund's incomplete adjuvant for all subsequent boosters. The immunization dose was 100 µg of Salmonella spp.-OMP mixture in a volume of 500 µL, equally divided between 4 injection sites on the pectoral muscle. Hens were boosted every 3 wk for a total of 12 wk. Two weeks after the last injection, eggs were harvested and the yolks were separated and pooled. The pooled egg yolks were then diluted 1:1 in distilled sterile water and stirred. The egg yolk mix was then frozen and freezedried to obtain HEYP. Nonimmunized egg yolk powder (NEYP), containing no anti-Salmonella spp. IgY, was prepared in the same manner, but from nonimmunized hens.
The experimental protocol was approved by the Official Animal Care and Use Committee of the Gembloux Agricultural University (protocol no. 05/04 NPC) before the initiation of research and followed the Belgian guidelines approved by the committee on care, handling, and sampling of the animals.
Experimental Feeds Preparation
A conventional mash feed for broiler chickens based on wheat, corn, and soybean meal and exempt from antimicrobials and coccidiostats was prepared (Table  1) . Thereafter, 7 feeds assigned to the egg yolk powder (EYP)-treated groups were individually prepared by mixing the conventional feed thoroughly with the designated mix of EYP at the required ratio of HEYP and NEYP as shown in Table 2 . The positive control feed (Table 1) was prepared by mixing the conventional feed with casein and soy oil so that the 8 experimental feeds were isoenergetic and isoprotein. The mean chemical compositions of EYP-supplemented feeds and positive control feed are given in Table 1 .
ELISA
Triplicate 1-g samples of each experimental feed were soaked in 10 mL of PBS and vortexed thoroughly. The samples were then centrifuged at 5,000 × g for 10 min at 4°C. The supernatant was collected and stored at −20°C until total IgY concentration determination and Salmonella spp. specific IgY titration. The total IgY concentration was determined by Chicken IgG ELISA Quantitation Kit (E30-104, Bethyl Laboratories Inc., Montgomery, TX; Chalghoumi et al., 2008) . Anti-Salmonella Enteritidis and anti-Salmonella Typhimurium IgY activities were determined as described previously (Chalghoumi et al., 2008) . The ELISA microtiter plate wells were coated, respectively, with Salmonella Enteritidis or Salmonella Typhimurium-OMP antigens that were used for the immunization of hens. Supernatants were serially double-diluted to obtain final dilutions ranging from 1:200 to 1:6,400 before being added to the wells. Anti-Salmonella Enteritidis and anti-Salmonella Typhimurium IgY titers in each experimental feed were defined as the reciprocal of the dilution giving half maximum absorbance read at 405 nm.
Challenge Inoculum Preparation
Salmonella Enteritidis and Salmonella Typhimurium strains used in this experiment were obtained from the Walloon Center of Industrial Biology (Gembloux, Belgium) collection and are the same strains that were exploited for obtaining the OMP antigens used for the immunization of hens. Organisms were retrieved from suspensions stored at −80°C, independently plated on Salmonella-Shigella agar (BK022HA, Biokar Diagnos-tics, Pantin Cedex, France), and incubated at 37°C overnight. Subsequently, 1 colony of Salmonella Enteritidis or Salmonella Typhimurium was individually placed in 10 mL of tryptone soy broth (TSB, BK046HA, Biokar Diagnostics) and incubated overnight at 37°C. Five milliliters of Salmonella Enteritidis or Salmonella Typhimurium preculture was separately transferred into 100 mL of TSB and incubated overnight at 37°C. The concentration of each bacterial suspension was then adjusted to a viable cell count of 2 × 10 6 cfu/mL after plate counting on Salmonella-Shigella agar. The challenge inoculum was prepared by mixing the required volumes of the adjusted Salmonella Enteritidis and Salmonella Typhimurium suspension to give a final viable cell concentration of 2 × 10 6 cfu/mL of Salmonella spp. (i.e., 1 × 10 6 Salmonella Enteritidis cfu/0.5 mL + 1 × 10 6 Salmonella Typhimurium cfu/0.5 mL) and was immediately used for the oral infection.
Birds and Infection
The experimental protocol was approved by the Official Animal Care and Use Committee of Gembloux Agricultural University (protocol no. fusagx 08/04 NPC) before the initiation of research and followed the Belgian guidelines approved by the committee on care, handling, and sampling of the animals. 3 Amino acids were analyzed by appropriate methods according to AFNOR (1998) norm. 4 The AME value was calculated by the method of Fisher and McNab (1987) . Three hundred eighty-four 1-d-old male Ross 308 broiler chicks from a Salmonella-free local commercial hatchery (Couvoir Vervaeke) were used to evaluate the protective efficacy of HEYP to simultaneous exposure to Salmonella Enteritidis and Salmonella Typhimurium. Upon the arrival of chicks, cloacal swabs and fecal samples were collected and tested for Salmonella spp. in an accredited laboratory (Association Régionale de Santé et d'Indentification Animales, Ciney, Belgium) according to the Annexe D ISO 6579 norm to confirm their Salmonella spp.-free status. All chicks were negative for Salmonella spp. After sampling, chicks were randomly distributed into 48 floor pens in a completely randomized design (8 treatments × 6 replications, each replication included 8 chicks). The 8 experimental groups were designated as follows: (1) 5 groups, T1, T2, T3, T4, and T5 (to be challenged with Salmonella spp. mix), were fed supplemented feeds of 5% (wt/wt) EYP, containing 5 different ratios of HEYP and NEYP; (2) 1 positive control, PC (to be challenged with Salmonella spp. mix), was fed an EYP-free feed; and (3) 2 negative controls, NC1 and NC2 (to remain unchallenged with Salmonella spp. mix), were fed, respectively, a supplemented feed of 5% (wt/wt) HEYP or NEYP (Table  2) .
Three days later, chicks (4 d old) were orally inoculated with Salmonella spp. mix (2 × 10 6 cfu/mL per chick), using a syringe and blunt-end catheter. Based on results obtained from previous trials in our laboratory, this infection protocol has proven to result in experimentally infected birds that are consistently and uniformly colonized with Salmonella. Chicks in the 2 negative control groups were inoculated with sterile TSB. Two days postinoculation, the infection was confirmed by checking fecal samples from each pen (n = 48). All infected pens were positive for Salmonella spp. In all groups, chicks were fed their assigned feed ad libitum from the beginning (d 1) to the end of the experiment (d 28). The negative control groups were housed in a separate room to prevent Salmonella contamination from groups to be challenged to the negatives control chickens.
Performance Monitoring
During the experimental period (d 7 to 28), feed intake per cage and individual BW were recorded weekly to calculate daily BW gain (g/bird per day) and feed conversion ratio (FCR) on a cage weight basis. Mortality was monitored daily.
Enumeration of Salmonella by Quantitative
Real-Time PCR Sample Collection. On d 7, 14, and 21, six chickens (1 chicken/pen) were killed from each group with an intracardiac injection of Nembutal (1 mL/kg, CEVA Santé Animale, Libourne, France) and samples of cecal digesta were aseptically taken and immediately frozen until DNA extraction for the enumeration of Salmonella spp. On d 28, eighteen chickens (3 chickens/pen) were killed, in the same manner, from each group and samples of cecal digesta were also aseptically taken and immediately frozen until DNA extraction for the enumeration of Salmonella spp.
DNA Extraction. Deoxyribonucleic acid extraction was carried out using the QIAamp DNA stool kit (Qiagen, Venlo, the Netherlands; Li et al., 2003) with some modifications to improve the extraction yield. Samples (1 g) of cecal contents were aseptically weighed in sterile Falcon tubes (BD Biosciences, San Jose, CA), diluted in 10 mL of lysis buffer, mixed thoroughly, and incubated at 70°C for 5 min. Two milliliters of each sample was placed in a bead-beating tube and placed in a bead beater and shaken for 3 min. The tubes were incubated at 70°C for 5 min and then centrifuged at 13,000 × g for 3 min. The aqueous phase was recovered in an Eppendorf tube (Eppendorf France SARL, Le Pecq, France) and subjected to the subsequent steps of the extraction protocol according to the instructions of the manufacturer. Deoxyribonucleic acid concentration in each sample was determined using the Quantit assay kit (Invitrogen SA, Merelbeke, Belgium). Extracted DNA was stored at −20°C.
Salmonella Enumeration. A TaqMan quantitative PCR assay was developed using an existing primer set that targeted a 284-bp fragment of Salmonella genusspecific invA gene originally published by Rahn et al. (1992) and suggested as an international standard for PCR detection of Salmonella spp. (Malorny et al., 2003) . The sequences of the primers pair were as follows: 5′-GTGAAATTATCGCCACGTTCGGGCAA-3′and 5′-TCATCGCACCGTCAAAGGAACC-3′. A TaqMan probe targeting the amplicon was designed in accordance with general guidelines: 5′-FAM-TTATTGGC-GATAGCCTGGCGGTGGGTTTTGTTG-TAMRA-3′ as previously reported by Hein et al. (2006) . The GenBank program BLAST was used to ensure that these oligonucleotide sequences were complementary with the target species. Primers and probe were manufactured by Eurogentec (Seraing, Belgium).
Polymerase chain reaction specificity was determined using 27 strains comprising 9 Salmonella spp. strains and 18 non-Salmonella spp. strains belonging to the common chicken intestinal microflora or species related to Salmonella spp. (Table 3 ). The specificity test showed that the inclusivity and the exclusivity were 100%. To determine the sensitivity of our PCR TaqMan quantitative PCR assay, 10-fold serial dilutions of target DNA extracted from a quantified mix of Salmonella Enteritidis and Salmonella Typhimurium pure cultures was performed. Twenty nanograms of DNA pooled from the 18 non-Salmonella spp. strains was added to each Salmonella spp. DNA dilution to quantify Salmonella in more complex matrix. The absence of PCR inhibitors in DNA samples extracted from the cecal contents samples has been also checked. A well-defined amount of Salmonella spp. DNA was added to a quantified DNA sample extracted from Salmonella-free cecal contents and was then amplified by PCR as described below. Salmonella spp. DNA that was added to DNA from cecal samples was amplified successfully.
All PCR reactions were performed in a final volume of 25 µL containing 12.5 µL of TaqMan Mix (2×; Applied Biosystems, Lennik, Belgium), 0.75 µL (20 µM) of each primer, 0.5 µL (10 µM) of the TaqMan probe, 10 µL of DNA (100 ng), 0.625 µL of BSA (4 µg/µL), and 0.625 µL of PCR-grade water. A negative control (containing all reagents except target DNA) and a positive control were included in each run.
A Salmonella spp. standard curve was made by diluting (10-fold serial dilution) a well-defined concentration of DNA extracted from Salmonella spp. pure culture to obtain invA copy numbers ranging from 2 × 10 5 to 2 × 10 1 copies. The standard curve was calculated automatically by plotting the cycle threshold against each standard dilution and the linear regression line of this curve was calculated. The slope and the correlation coefficient (r 2 ) of the standard curve were calculated for each run. The efficiency of the PCR reactions was around 95%. Unknown copy numbers were determined automatically by interpolation from standard curve. Samples and standards were analyzed in triplicate. Deoxyribonucleic acid amplification and quantification were performed using StepOne Plus Real-Time PCR System (Applied Biosystems Inc., Foster City, CA). Each PCR reaction consisted of the following steps: 10-min initial denaturation at 95°C to activate the polymerase, followed by 40 cycles of 15-s denaturation at 95°C, 1 min annealing, and elongation at 64°C. Data were collected at the end of each elongation step and data analysis was performed using the StepOne Software v2.0 (Applied Biosystems Inc.).
Efficacy of Treatment
In the EYP-treated groups (T1, T2, T3, T4, T5), the efficacy of each treatment with respect to the PC group was assessed from the values of the infection factor (IF) and the protection factor (PF) as described by Mead et al. (1989) . The IF is the geometric mean of the number of Salmonella (expressed in log 10 cfu per gram of cecal content) for all sampled chickens in a particular EYPtreated group. The PF is obtained by dividing the IF value for the PC group by that for the EYP-treated group (Mead et al., 1989) .
Statistical Analysis
Chicken growth performance data were analyzed using a mixed linear model of the MIXED procedure of SAS 8.02 software. The model fitted treatment as fixed classified effect, BW on d 7 as covariable, and treatment location (block) and treatment × block interaction as random effects. The use of the BW at d 7 as covariable is justified by the fact that at the beginning of the experiment (d 1), when experimental treatments were assigned to chicken groups, birds had similar BW; however, at the beginning of the performance parameter measurement (d 7), the BW were significantly different (P < 0.001) among the treatment groups. Salmonella counts in cecal samples of each Salmonella-challenged group were log-transformed to normalize them before analysis. At each sampling day, statistical analyses of Salmonella populations were done according to a mixed linear model of the MIXED procedure of SAS 8.02 software (SAS Institute, 1999 ). The statistical model fitted treatment as the classified effect and treatment location (block) and treatment × block interaction as random effects. Individual bird was considered the experimental unit.
For Salmonella spp. counts and growth performance data, different covariance structures were tested to model the random block effect. The smallest value for the Akaike's information criteria was used to select the most appropriate covariance structure. Differences between levels of the fixed effect (treatment) were tested using an F-test and were declared significant at P < 0.05.
Regarding IF and PF data, given the small number of observations per treatment and per sampling day, only a statistical analysis over the entire experimental period was conducted. Statistical differences between treatments groups were tested using a mixed linear model of the MIXED procedure of SAS 8.02 software. The model fitted treatment as the fixed classified effect and the day of sampling as repeated effect. Differences between treatment levels were tested using an F-test and were declared significant at P < 0.05.
For all data (growth performance, Salmonella spp. counts, IF, and PF), linear, quadratic, and cubic effects of the anti-Salmonella IgY concentration were tested with a contrast statement in the MIXED procedure of SAS 8.02. The coefficients used in these contrast statements were generated with IML procedure of SAS 8.02 software.
RESULTS
All the EYP-supplemented feeds had similar proximate total IgY concentrations (0.667 ± 0.09 g/kg of feed). They differed only in their specific antibody titers (Table 4) , given the difference in the incorporation rates of the HEYP in the feeds. Although the NC2 and T5 groups received NEYP-amended feed, the presence of a nonnegligible anti-Salmonella spp. IgY titer (1:200) was measured in their respective feeds. However, this titer is 8 or 12.5 times lower than that of anti-Salmonella Enteritidis (1:1,600) and anti-Salmonella Typhimurium (1:2,500) IgY titers, respectively, determined in feed of the T1 group that received the highest HEYP concentration (5%).
Clinical Signs and Mortality
No clinical symptom associated with Salmonella infection was observed. The mortality rate (data not shown) in the infected chicken groups (T1, T2, T3, T4, T5, and PC) was not higher than that of the negative control groups (NC1 and NC2). The overall average mortality rate during the experiment was 3.4%.
Growth Performance
Chicken growth performance data throughout the experiment are presented in Table 5 . The effects of the treatment location (block) and the treatment × block interaction on growth performance were not significant.
Throughout the experimental period, it was shown that the growth performance data (BW, feed intake, BW gain, and FCR) in the negative control group provided feed supplemented with the highest concentration level of anti-Salmonella spp. IgY (NC1: 5% of HEYP) were statistically similar to those observed in the negative control group fed the same basic diet but unsupplemented with anti-Salmonella spp. IgY (NC2: 0% of HEYP). As shown in Table 5 , feed intake levels were significantly different between treatments during the observation period. The highest feed intake was recorded in negative control groups (NC1 and NC2), whereas the lowest feed intake was observed in the PC group. Birds in challenged and EYP-treated groups (T1, T2, T3, T4, and T5) had statistically similar feed intake that averaged 64.33 g/bird per day. This ADFI was lower than that of NC1 and NC2 groups but higher than that of PC groups (P < 0.05).
Although at the beginning of the experiment (on d 1), the PC group had similar BW as the NC2 group, later the former chicken group performed significantly worse than the latter one. On d 28, a significant difference equal to 409 g was calculated between the BW of the 2 groups. Additionally, in the PC group, the BW gain decreased by 24.9% and the FCR increased by 6.4%, as compared with the NC2 group.
The comparison of T1, T2, T3, T4, and T5 treatment groups does not reveal any anti-Salmonella spp. IgY concentration effect on any of the performance parameters listed in Table 5 . The linear, quadratic, and cubic effects of anti-Salmonella spp. IgY concentration were never found to be significant.
Regardless of the anti-Salmonella spp. IgY concentration incorporated in the feed, BW gain and the FCR in T1, T2, T3, T4, and T5 groups were statistically similar but significantly better than those of PC group. Indeed, EYP inclusion in infected chicken feeds led to a significant improvement of growth performance, enhancing feed intake by 17.8%, increasing the BW gain by 15.5%, and decreasing FCR by 7.1%, as compared with PC group. As consequence, T1, T2, T3, T4, and T5 chickens were on average 219 g heavier than the PC chickens.
The BW gain in T1, T2, T3, T4, and T5 groups was significantly lower than that in NC1 and NC2 groups. The overall average BW gain from the 5 former treatment groups was 49.3 g/bird per day, whereas that from the 2 latter ones was 54.6 g/bird per day, that is to say a difference of 9.7%. The same tendency was observed for the final BW data. Average final BW in T1, T2, T3, T4, and T5 groups (1,239 g) was almost 182 g lower than that of NC1 and NC2 (1,420.5 g). Surprisingly, the FCR in T1, T2, T3, T4, and T5 groups were statistically similar to those of NC1 and NC2 groups.
Salmonella Colonization Level of Ceca
The cecal samples recovered from the negative control chickens in the NC1 and NC2 groups were free of Salmonella spp. throughout the experiment period.
When evaluated over the whole observation period, the IF values in all groups, including the PC group, were statistically similar. The same goes for the PF values (data not shown).
The effect of EYP-amended feed treatments on the cecal colonization by Salmonella on the individual observation days is presented in Table 6 . At every sampling day (d 7,14, 21, and 28), the molecular enumeration showed no significant difference in the number of Salmonella spp. found in the cecum of the T1, T2, T3, T4, or T5-treated birds as compared with the PC birds.
When one compares T1, T2, T3, T4, and T5 on d 7, there is a trend toward a nearly significant difference (P = 0.0636) between these 5 treatments. This trend corresponds to a significant (P < 0.05) linear HEYP concentration effect on Salmonella spp. cecal colonization. It has been found that T1 is more effective (P = 0.0315) than T2, T3, T4, and T5 in reducing Salmonella spp. cecal colonization. In contrast, on d 14, 21, and 28, no linear, quadratic, or cubic effect of the HEYP concentration in feed treatments on Salmonella numbers in ceca has been observed.
The monitoring over time of Salmonella spp. counts in ceca for each treatment group shows that this parameter remained statistically unchanged in T1, T3, and T4 groups (P > 0.05), whereas it decreased significantly in T2 (P = 0.0396), T5 (P = 0.0396), and PC Least squares means within each row without a common letter are significantly different (P < 0.05). 1 Chick groups fed on d 1 onward with their designed egg yolk powder-supplemented (T1, T2, T3, T4, T5, NC1, and NC2) or unsupplemented (PC) feed-and kept unchallenged (NC1 and NC2) or challenged on d 4 with Salmonella spp. mix (T1, T2, T3, T4, T5, and PC). Performance parameters (BW, feed intake, BW gain, and feed conversion ratio) were monitored weekly throughout the observation period (d 7 to 28).
2 Values represent the least squares means of the entire observation period (d 7 to 28). T = treatment; PC = positive control; NC = negative control.
3 Percentage of hyperimmune egg yolk powder in feed; percentage of wet matter.
(P = 0.0396) groups. The difference in cecal Salmonella counts between d 7 and 28 was 1.52, 2.66, and 2.52 log 10 cfu/g, respectively, for T2, T5, and PC groups. Expressing the level of cecal colonization on the basis of the total content of cecum does not change anything about the way in which results are interpreted above.
DISCUSSION
Salmonella Enteritidis and Salmonella Typhimurium are capable of causing highly virulent systemic disease in young chicks of less than 3 d of age, but in older birds, they lead to persistent colonization of the gastrointestinal tract without causing discernible illness (Barrow et al., 1987; Ziprin et al., 1989; Holt et al., 1999; Beal et al., 2004) . Although this is rarely observed, Salmonella experimental infection course in broiler chickens may be accompanied by a decrease in growth performance (Hegazy and Adachi, 2000; Nakamura et al., 2002) . In these 2 studies, a BW gain decrease of 12.9 and 12.6% was recorded, respectively, in Salmonella Typhimurium-challenged chickens as compared with the unchallenged birds. In the first part of the current work, we evaluated the effect of anti-Salmonella spp. IgY feed supplementation on an eventual decrease in growth performance linked to Salmonella infection.
As mentioned above, the negative effect of Salmonella Enteritidis and Salmonella Typhimurium infection on broiler chicken growth performance is rarely stated in the scientific literature (Hegazy and Adachi, 2000; Nakamura et al., 2002) . However, in the present study, Salmonella carriage was with symptoms, such as growth performance deterioration. Our challenge model (2 × 10 6 cfu/bird) showed a significant deterioration in growth performance in 4-d-old Salmonella Enteritidis and Salmonella Typhimurium co-challenged chickens, with a BW gain decrease of 24.9% and a FCR increase of 6.4%. These results are in accordance with those obtained in a previous work in our laboratory (our unpublished data) that showed in 3-d-old chickens a very pronounced decrease of growth performance by 20 to 30% for BW gain and 2 to 20% for the FCR, after Salmonella Typhimurium inoculation at 1 × 10 5 to 1 × 10 8 cfu/bird. Nevertheless, our results are in contrast to the encountered effect of both pathogens in a commercial setting, where such growth performance decrease is rarely observed. The challenge dose experienced in our experiment is relatively high compared with that observed in commercial poultry flocks. This may partly explain the Salmonella symptomatic carriage observed in this experiment. Indeed, the Salmonella infection effect is variable depending on the age of the chicks (1-d-old chicks are more sensitive to infection than those of 1 wk of age; Gast and Beard, 1989) , the challenge dose used (Humphrey et al., 1991; Dhillon et al., 1999) , strain of Salmonella (Barrow, 1991; Dhillon et al., 1999) , and type of birds (Duchet-Suchaux et al., 1997; meat-type chickens are more resistant than eggtype chickens; Gast and Benson, 1995) . These factors explain the discrepant results reported by researchers.
The poor growth performance observed in this study in the PC group is at first sight related to feed intake (Table 5 ). This parameter was adversely affected in this group during the experiment. In this respect, it has been reported that about 70% of the reduced growth rate that occurs during an infection challenge can be attributed to decreased feed intake (Humphrey and Klasing, 2004) . The decrease in feed intake that accompanies an infectious challenge is a consequence of a decrease in appetite (Klasing, 2007) . Indeed, when the immune system detects a pathogen, it triggers a systemic alarm, the acute phase response, which modulates the metabolism of the animal and leads to a decrease in the appetite.
The negative effect of Salmonella infection on chicken performance may also be related to low nutrient absorption or low nutrient availability. Regarding the first hypothesis, it has been shown that Salmonella spp. invasion in broiler chickens leads to different changes in villus height, crypt depth (Borsoi et al., 2009) , strong inflammatory response (Kaiser et al., 2000; Fasina et al. 2008) , and cell infiltration (Borsoi et al., 2009 ), resulting in intestinal lesions that might lead to the dysfunction of the intestinal epithelium and therefore the impairment of nutrient absorption. Observations consistent with this hypothesis have been previously made in our laboratory (Chalghoumi et al., 2009 ), but on a human adenocarcinoma intestinal (Caco-2) cell line model. Indeed, in this epithelial cell model, Salmonella Enteritidis and Salmonella Typhimurium strains used in the present study were able after 90 min of co-incubation with epithelial cells to disrupt the Caco-2 cells monolayer integrity. As to the second hypothesis, it has been shown that the decrease in feed intake accounts for most of the decrease in nutrients available to an animal during most infections (Humphrey and Klasing, 2004) . Furthermore, it was demonstrated that when the immune system responds to a pathogen, it triggers several anabolic processes, particularly a proinflammatory response, which increases nutrient use (particularly that of amino acids) by the immune system to the detriment of all other physiological and development processes, such as growth and reproductive processes (Grimble, 2006; Sirimongkolkasen, 2007) .
Our results also demonstrate that in-feed inclusion of EYP enhanced significantly the feed intake and growth of infected chickens but did not reach the same performance level of the unchallenged birds and those fed EYP (Table 5) . Indeed, in the T1, T2, T3, T4, and T5 groups, performance was in between that of the PC group and that of the NC1 and NC2 groups. Interestingly, the T1, T2, T3, T4, and T5 groups have FCR similar to those of the NC1 and NC2 groups. This suggests that the low growth rate observed in the EYP-supplemented and infected chickens with respect to negative control groups is not the result of a poor conversion of the ingested feed but rather that of a low feed intake.
No link can be established between the improved performance of challenged birds and their contamination levels by Salmonella because in-feed incorporation of EYP had no effect on cecal colonization by Salmonella. This goes against the results of other passive immunization studies using EYP, in which better growth rates were achieved as consequence of a significant decrease in rotavirus (Özpinar et al., 1996) or Escherichia coli (Marquardt et al., 1999; Owusu-Asiedu et al., 2003) carriage.
Apparently, the enhanced effect of EYP on the growth performance of challenged chickens could not be mediated by anti-Salmonella spp. IgY. This is first supported by the fact that the T5 group performed significantly better than PC group (Table 5) . Although nonnegligible anti-Salmonella spp. IgY activity was observed in the feed of this group, this activity is very likely attributed to nonspecific IgY that could crossreact with OMP antigen in ELISA. Indeed, hens used for the production of both of HEYP and NEYP are certified specific Salmonella spp.-free and unvaccinated against Salmonella. Thus, the enhanced effect of nonspecific IgY present in the EYP on the growth performance of infected birds cannot be excluded. The hypothesis advanced above regarding the effect of specific IgY can be also supported by the absence of any antiSalmonella IgY concentration effect on the performance of challenged chickens. Even though this finding is logical because no reduced levels of Salmonella contamination were attributed to the effect of anti-Salmonella IgY concentration in feed, it can be alternatively speculated that the level of nonspecific IgY present in the feed of the T5 group that could cross-react with Salmonella already corresponds to the effective dose. This hypothesis is unlikely because despite the anti-Salmonella spp. activity measured in the feed of the T5 group, this treatment was unable to reduce the level of cecal colonization by Salmonella as compared with PC treatment (Table 6 ). Taken together, these results indicate that specific antibodies have no growth promoter effect and components of EYP other than specific antibodies, presumably nonspecific IgY, have a beneficial effect on growth performance. This hypothesis is sustained by the fact that the NC1 group showed the same growth performance as the NC2 groups. In this case, it can be suggested that IgY as a high-value protein (i.e., independently of its specific activity against Salmonella) would improve the nutritional quality of the feed.
Apart from the specific and nonspecific IgY, it is well known that yolk is a plentiful source of biologically active components (Mine and Kovacs-Nolan, 2004) . However, as far as we are aware, most of these components have no direct growth promoter effect recorded in the scientific literature, with the exception of n-3 fatty acids. The beneficial effects of dietary n-3 acids on growth and feed intake of broiler chickens (Fritsche et al., 1991) and pigs (Van Oeckel et al., 1997) have been previously demonstrated.
In the second part of the study, we evaluated the cecal colonization by Salmonella to assess the effectiveness of the in-feed inclusion of HEYP containing specific antibodies to prevent intestinal colonization in broiler chickens. It is important to remember here that orally administered antibodies are only expected to act locally in the intestinal tract by preventing Salmonella growth and adherence to the intestinal epithelial cell and thereby subsequent bacterial invasion of the intestine. Indeed, because of their high molecular weight (180 kDa), IgY are unable to cross the intestinal barrier and enter the systemic circulation. Thus, passive immunization by oral administration of specific antibodies is an ineffective approach when Salmonella infection becomes systemic. However, even if a systemic infection occurs, this does not undermine the effectiveness of these antibodies at the intestinal level because the internal organ colonization level by Salmonella, such liver and spleen, does not affect the intestinal colonization and the fecal excretion of the microorganism.
Using a Salmonella Enteritidis and Salmonella Typhimurium co-challenge model, we were unable to demonstrate the ability of specific IgY to reduce the level of cecal colonization of these pathogens in broiler chickens. These results are in contrast to those noted for IgY with specific activity against Enterobacteriaceae such as Campylobacter jejuni (Tsubokura et al., 1997) and Salmonella Enteritidis (Rahimi et al., 2007) in broiler chickens and Salmonella Enteritidis in laying hens (Kassaify and Mine, 2004) , wherein a decrease of 99, 93, and 100%, respectively, of the fecal shedding or cecal colonization has been noted. This difference can be due to experimental conditions used in these studies, which are different from ours regarding the antibody concentration administrated, the route of antibody administration, and the challenge pathogen. In the present work, birds were given approximately 50 mg of total IgY/d per bird, whereas in Kassaify and Mine (2004) and Rahimi et al. (2007) , they received, respectively, 166 and 100 mg of total IgY/d per bird [based on the amounts of HEYP administrated to the birds and the mean concentration of IgY in egg yolk cited by Schade et al. (2005) ]. Furthermore, in the latter study, antibodies were administrated in the drinking water. This would have enabled the antibodies to leave the gizzard (the site of pepsic digestion) quickly and therefore to be less exposed to the digestive conditions. Tsubokura et al. (1997) had an experimental approach different from ours: 0.5 g of IgY preparation with a purity rate of 95% was preincubated with 1 × 10 6 cfu bacteria before their administration as a single dose to 14-d-old broiler chickens.
Based on this comparison, it can be speculated that the HEYP concentrations administrated in the present study were not high enough to allow the setting of a high level of immunologically active intact anti-Salmonella spp. IgY able to exacerbate a protective effect against Salmonella spp. intestinal colonization. This hypothesis is supported by a slight decrease on d 7 in cecal colonization of Salmonella in the HEYP-amended feed treatments as compared with the PC group, which would mean that anti-Salmonella spp. IgY titers present in the intestinal tract of the birds at the time of challenge (d 4) have been only partially able to prevent the installation of Salmonella. Besides, the statistical analysis revealed that this slight decrease is HEYP concentration-dependent. This finding reinforces our hypothesis that the administered HEYP concentrations were initially low in our experiment.
To what extent these concentrations were inappropriate is questionable. Orally administered antibodies, like any other protein, are susceptible to denaturation by the acidic pH of the stomach and degradation by proteases. However, it has been shown (in 28-d-old broiler chickens) that IgY activity remained detectable for 48 h in the cecum after administration in feed (Wilkie et al., 2006) . Moreover, it has been found that components from the egg yolk proteolipidic matrix appeared to be significantly effective in protecting the antibodies from the digestive process in vitro (Schmidt et al., 1989; Jaradat and Marquardt, 2000) . Based on these facts, we administered IgY as whole EYP mixed to the feed assuming that these antibodies will be somewhat protected against the digestive process and therefore can reach the cecum to a large extent. However, it has also been shown that even though antibodies were embedded in the egg yolk proteolipidic matrix, their activity decreased by 74.2 and 13.7% after incubation for 30 min at pH 2 and 3, respectively (Marcq et al., 2008) . For this reason, we also studied the HEYP concentration effect starting from a concentration of 5% (maximum tolerated incorporation level in broiler feed) to erase the possible loss in activity due to hostile conditions of the upper digestive tract. However, as noted earlier, antibody dose administered in the studies cited above was higher than ours. This suggests that under high antibody doses, sufficient amounts of immunologically active antibodies could reach the cecum in spite of the IgY activity decrease caused by the digestive process. According to this hypothesis, under a low dose such as ours, IgY has to be protected before its oral administration to the birds.
On the assumption that the administrated HEYP concentrations were initially insufficient, it would be logical that the HEYP-supplemented feed treatments had no effect on the subsequent Salmonella spp. cecal colonization through the experiment, especially if Salmonella that might have escaped the action of the specific IgY on d 4 were able to multiply so much so that the daily inflow of the immunologically active antiSalmonella spp. IgY in the intestinal tract was completely insufficient to exacerbate any protective effect against Salmonella spp. intestinal colonization.
In the current study, birds were orally gavaged with a consistent titer of Salmonella spp. (2 × 10 6 cfu/bird). This challenge dose was chosen in an attempt to ensure a consistent and uniform level of colonization from an experimental point of view. Indeed, for both Salmonella Enteritidis and Salmonella Typhimurium, a review of the literature indicated that a challenge dose of 1 × 10 5 cfu/bird or less resulted in inconsistently colonized birds (Barrow, 1991; Bjerrum et al., 2003; Stern, 2008) . In all likelihood, even this challenge dose is artificially high relative to the infectious dose encountered in commercial poultry flocks. Therefore, it is possible that this high challenge dose would have masked the IgY potential and that under lower challenge doses, more representative of a commercial setting, a better outcome may have been observed.
As stated above, the challenge pathogen may be a determining factor. Here, a co-challenge model has been used: chickens were inoculated with both pathogens at the same time. It is very likely that the IgY concentrations tested in this study were not sufficient to overcome the simultaneous colonization of both pathogens. It can be also speculated that the simultaneous presence of the 2 pathogens in the intestinal tract increased the virulence mechanisms of one or both serovars, in particular their growth rate. Moreover, because the age and type of birds used vary from one study to another, results may also be different.
In conclusion, our results suggest that the in-feed inclusion of specific IgY simultaneously directed against Salmonella Enteritidis and Salmonella Typhimurium does not reduce cecal colonization of the microorgan-isms in experimentally co-challenged broilers. Results were not encouraging, probably owing to initially low administrated concentrations coupled to antibody degradation and denaturation after their passage through the animal gastrointestinal tract. A study that examines in vivo the resistance of protected antibodies (under multiple concentrations) to the digestive conditions of the gastrointestinal tract is required to determine which dose can deliver the highest level of intact antibodies in the cecum. Once the effective dose is defined, the performance of the protected anti-Salmonella spp. IgY should be evaluated again in Salmonella-challenged broiler chickens.
Unexpectedly, our results also indicate that in-feed inclusion of EYP improves significantly the performance of infected chickens, but not to the same level as that of the uninfected ones. The reasons for this improvement are unclear because anti-Salmonella spp. IgY effect on performance parameters was never found to be significant. The involvement of egg yolk compounds other than specific antibodies is possible and needs to be further investigated.
